+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Stem Cell Market Size Analysis Report By Product (Adult, hESC, Induced Pluripotent), By Application (Regenerative Medicine, Drug Discovery & Development), By Technology, By Therapy, And Segment Forecasts, 2019 - 2025

  • ID: 4764577
  • Report
  • 190 pages
  • Grand View Research
1 of 3

FEATURED COMPANIES

  • Angel Biotechnology
  • BIOTIME, INC.
  • Celgene Corporation
  • CellGenix GmbH
  • Genea BioCells
  • Lonza
  • MORE
The global stem cell market size is expected to reach USD 15.63 billion by 2025, at a CAGR of 8.8% during the forecast period. Amplifying research studies targeted at widening the utility scope of stem cell products is anticipated to drive the growth. These research projects are set to offer new opportunities for implementation of several clinical applications of stem cells. Thus, extensive research on exploring varied applications of stem cells would impact treatment options that aid in disease-modification.

In addition, collaborations targeted at achieving robust manufacturing of high-quality differentiated cells is expected open up new avenues of market expansion over the forecast period. Rapid transition from conventional treatment methods to regenerative medicine has been observed over the past few years. Regenerative medicine is set to become the new prototype of treatment in human health having the potential to address unmet medical needs across the globe. Integration of biologics, chemical compounds, materials, and devices is witnessed in stem cell therapeutics making it an interdisciplinary field.

Moreover, rising recognition of cellular therapies as an emerging revolutionary advancement has been witnessed in the healthcare industry in recent years. Business expansion is adopted by companies aiming at strengthening their portfolio regarding cellular therapy. This is expected to improve detailed understanding and future potential of stem cells for the of patients suffering from Parkinson's disease, diabetes, injuries associated with spinal cord, and other neurodegenerative disorders.

Further, a maturing and strongly diversified clinical pipeline is expected to contribute to the growth of stem cell market. Availability of latest data during the mid and late stage of the regenerative medicine clinical trials and increase in the product approvals regarding the same is expected to drive the market.

Adult stem cells displayed highest contribution in the market and is expected to maintain its dominance over the forecast period. Factors such as minimal ethical issues, lower rejection rates, and long-term renewal property associated with stem cells utility has contributed to the dominance of this segment. Moreover, the characteristic property of these cells to regenerate into malignant cells is anticipated to support the estimated share.

Scientists at Michigan State University revealed novel type of cells, named induced XEN cells, originated from a cellular trash pile in March 2016. The conclusions drawn from this research study is expected to drive emerging regenerative medicine treatment methods. In January 2019, research professionals at the University of Freiburg carried out research on the potential of mesenchymal stems cells in repairing damaged organs. This is further anticipated to boost research as well as sales in the market throughout the study period.

Further key findings from the report suggest:
  • Based on application regenerative medicine is estimated to hold a substantial market share in terms of revenue over the forecast period, owing to rise in emerging pipeline projects
  • Progress of acquisition technology is expected to gain momentum during the forecast period owing to the rising research projects that demand the use of harvesting techniques
  • Amongst the type of therapies used, autologous therapy accounted for the largest share of the stem cell market
  • Likelihood of getting new infections is less in autologous cell-based therapy, consequently enhancing its adoption
  • R&D activities carried out on large scale and huge funds granted by funding bodies to advance cellular research in U.S. have made North America the dominant region in the global market
  • Vast research studies taking place in Singapore and Japan is anticipated to propel the Asia Pacific market in the forthcoming years
  • Osiris Therapeutics Inc.; Celgene Corporation; BIOTIME, INC.; Cynata; Advanced Cell Technology Inc.; and STEMCELL Technologies Inc.; are some of the key market players
  • The companies are undergoing strategic partnership to enhance their product line. They are keen on seeking investments from overseas organizations along with adopting partnership strategies with pharmaceutical organizations, which is set to fuel the market growth.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Angel Biotechnology
  • BIOTIME, INC.
  • Celgene Corporation
  • CellGenix GmbH
  • Genea BioCells
  • Lonza
  • MORE
Chapter 1 Research Methodology
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased database
1.3.2 Internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing

Chapter 2 Executive Summary
2.1 Stem cell market outlook, 2014 - 2025

Chapter 3 Stem Cell Market: Industry Outlook
3.1 Penetration & growth prospects mapping
3.2 Pipleline analysis
3.3 Trend analysis
3.3.1 Product trends
3.3.2 Application trends
3.3.3 Technology trends
3.3.4 Therapy trends
3.4 Stem Cell Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Ongoing developments in regenerative medicine
3.4.1.2 Rising funds for accelerating stem cell research
3.4.1.3 Growing demand for stem cell banking
3.4.1.4 Increasing prevalence of genetic disorders
3.4.2 Market Restraint Analysis
3.4.2.1 Ethical concern related to stem cell research
3.4.2.2 Lack of well-defined regulatory framework in certain applications of stem cell
3.5 Opportunity analysis
3.6 Industry Analysis - Porter’s
3.6.1 Supplier power (more specifics)
3.6.2 Buyer power
3.6.3 Substitution threat
3.6.4 New entrants threat
3.7 Stem Cells - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.8 Competitive landscape
3.8.1 Strategy framework
3.8.2 Company categorization
3.8.2.1 New entrants
3.8.2.2 Mature players & leaders

Chapter 4 Stem Cell Market: Product Outlook
4.1 Stem cell market share by product, 2014 to 2025
4.2 Adult stem cell market, 2014 to 2025
4.2.1 Adult stem cell market revenue (USD Million), by region
4.3 Human embryonic stem cells
4.3.1 Human embryonic stem cell market revenue (USD Million), by region
4.4 Induced pluripotent stem cells
4.4.1 Induced pluripotent stem cell market revenue (USD Million), by region
4.5 Very small embryonic like stem cells
4.5.1 Very small embryonic like stem cell market revenue (USD Million), by region

Chapter 5 Stem Cell Market: Application Outlook
5.1 Stem cell market share by application, 2014 to 2025
5.2 Regenerative Medicine market, 2014 to 2025
5.2.1 Regenerative medicine market revenue (USD Million), by region
5.2.2 Neurology market, 2014 to 2025
5.2.2.1 Neurology market revenue (USD Million), by region
5.2.3 Orthopedics market, 2014 to 2025
5.2.3.1 Orthopedics market revenue (USD Million), by region
5.2.4 Oncology market, 2014 to 2025
5.2.4.1 Oncology market revenue (USD Million), by region
5.2.5 Hematology market, 2014 to 2025
5.2.5.1 Hematology market revenue (USD Million), by region
5.2.6 Cardiovascular and myocardial Infraction market, 2014 to 2025
5.2.6.1 Cardiovascular and myocardial infraction market revenue (USD Million), by region
5.2.7 Injuries market, 2014 to 2025
5.2.7.1 Injuries market revenue (USD Million), by region
5.2.8 Diabetes market, 2014 to 2025
5.2.8.1 Diabetes market revenue (USD Million), by region
5.2.9 Liver disorder market, 2014 to 2025
5.2.9.1 Liver disorder market revenue (USD Million), by region
5.2.10 Incontinence market, 2014 to 2025
5.2.10.1 Incontinence market revenue (USD Million), by region
5.2.11 Others market, 2014 to 2025
5.2.11.1 Others market revenue (USD Million), by region
5.3 Drug discovery and development market, 2014 to 2025
5.3.1 Drug discovery and development market revenue (USD Million), by region

Chapter 6 Stem Cell Market: Technology Outlook
6.1 Stem cell market share by technology, 2014 to 2025
6.2 Cell Acquisition market, 2014 to 2025
6.2.1 Cell acquisition market revenue (USD Million), by region
6.2.2 Bone marrow harvest market, 2014 to 2025
6.2.2.1 Bone marrow harvest market revenue (USD Million), by region
6.2.3 Umbilical blood cord market, 2014 to 2025
6.2.3.1 Umbilical blood cord market revenue (USD Million), by region
6.2.4 Apheresis market, 2014 to 2025
6.2.4.1 Apheresis market revenue (USD Million), by region
6.3 Cell production market, 2014 to 2025
6.3.1 Cell production market revenue (USD Million), by region
6.3.2 Therapeutic cloning market, 2014 to 2025
6.3.2.1 Therapeutic cloning market revenue (USD Million), by region
6.3.3 In vitro fertilization market, 2014 to 2025
6.3.3.1 In vitro fertilization market revenue (USD Million), by region
6.3.4 Cell culture market, 2014 to 2025
6.3.4.1 Cell culture market revenue (USD Million), by region
6.3.5 Isolation market, 2014 to 2025
6.3.5.1 Isolation market revenue (USD Million), by region
6.4 Cryopreservation market, 2014 to 2025
6.4.1 Cryopreservation market revenue (USD Million), by region
6.5 Expansion and sub-culture market, 2014 to 2025
6.5.1 Expansion and sub-culture market revenue (USD Million), by region

Chapter 7 Stem Cell Market: Therapy Outlook
7.1 Stem cell market share by therapy, 2014 to 2025
7.2 Autologous market, 2014 to 2025
7.2.1 Autologous market revenue (USD Million), by region
7.3 Allogenic
7.3.1 Allogenic market revenue (USD Million), by region

Chapter 8 Stem Cell Market: Regional Outlook
8.1 Stem cell market Share by Region, 2018 & 2025
8.2 North America
8.2.1 North America stem cell market, by product 2014 - 2025 (USD Billion)
8.2.1.1 North America adult stem cell market, by product 2014 - 2025 (USD Billion)
8.2.2 North America stem cell market, by application 2014 - 2025 (USD Billion)
8.2.2.1 North America regenerative medicine market, by application 2014 - 2025 (USD Billion)
8.2.3 North America stem cell market, by technology 2014 - 2025 (USD Billion)
8.2.3.1 North America cell acquisition market, technology 2014 - 2025 (USD Billion)
8.2.3.2 North America cell production market, by technology 2014 - 2025 (USD Billion)
8.2.4 North America stem cell market, by type 2014 - 2025 (USD Billion)
8.2.5 U.S.
8.2.5.1 U.S. stem cell market, by product 2014 - 2025 (USD Billion)
8.2.5.1.1 U.S. adult stem cell market, by product 2014 - 2025 (USD Billion)
8.2.5.2 U.S. stem cell market, by application 2014 - 2025 (USD Billion)
8.2.5.2.1 U.S. regenerative medicine market, by application 2014 - 2025 (USD Billion)
8.2.5.3 U.S. stem cell market, by technology 2014 - 2025 (USD Billion)
8.2.5.3.1 U.S. cell acquisition market, technology 2014 - 2025 (USD Billion)
8.2.5.3.2 U.S. cell production market, by technology 2014 - 2025 (USD Billion)
8.2.5.4 U.S. stem cell market, by type 2014 - 2025 (USD Billion)
8.2.6 Canada
8.2.6.1 Canada stem cell market, by product 2014 - 2025 (USD Billion)
8.2.6.1.1 Canada adult stem cell market, by product 2014 - 2025 (USD Billion)
8.2.6.2 Canada stem cell market, by application 2014 - 2025 (USD Billion)
8.2.6.2.1 Canada regenerative medicine market, by application 2014 - 2025 (USD Billion)
8.2.6.3 Canada stem cell market, by technology 2014 - 2025 (USD Billion)
8.2.6.3.1 Canada cell acquisition market, technology 2014 - 2025 (USD Billion)
8.2.6.3.2 Canada cell production market, by technology 2014 - 2025 (USD Billion)
8.2.6.4 Canada stem cell market, by type 2014 - 2025 (USD Billion)
8.3 Europe
8.3.1 Europe stem cell market, by product 2014 - 2025 (USD Billion)
8.3.1.1 Europe adult stem cell market, by product 2014 - 2025 (USD Billion)
8.3.2 Europe stem cell market, by application 2014 - 2025 (USD Billion)
8.3.2.1 Europe regenerative medicine market, by application 2014 - 2025 (USD Billion)
8.3.3 Europe stem cell market, by technology 2014 - 2025 (USD Billion)
8.3.3.1 Europe cell acquisition market, technology 2014 - 2025 (USD Billion)
8.3.3.2 Europe cell production market, by technology 2014 - 2025 (USD Billion)
8.3.4 Europe stem cell market, by type 2014 - 2025 (USD Billion)
8.3.5 Germany
8.3.5.1 Germany stem cell market, by product 2014 - 2025 (USD Billion)
8.3.5.1.1 Germany adult stem cell market, by product 2014 - 2025 (USD Billion)
8.3.5.1 Germany stem cell market, by application 2014 - 2025 (USD Billion)
8.3.2.2 Germany regenerative medicine market, by application 2014 - 2025 (USD Billion)
8.3.5.3 Germany stem cell market, by technology 2014 - 2025 (USD Billion)
8.3.5.3.1 Germany cell acquisition market, technology 2014 - 2025 (USD Billion)
8.3.5.3.2 Germany cell production market, by technology 2014 - 2025 (USD Billion)
8.3.5.4 Germany stem cell market, by type 2014 - 2025 (USD Billion)
8.3.6 U.K.
8.3.6.1 U.K. stem cell market, by product 2014 - 2025 (USD Billion)
8.3.6.1.1 U.K. adult stem cell market, by product 2014 - 2025 (USD Billion)
8.3.6.2 U.K. stem cell market, by application 2014 - 2025 (USD Billion)
8.3.6.2.1 U.K. regenerative medicine market, by application 2014 - 2025 (USD Billion)
8.3.6.3 U.K. stem cell market, by technology 2014 - 2025 (USD Billion)
8.3.6.3.1 U.K. cell acquisition market, technology 2014 - 2025 (USD Billion)
8.3.6.3.2 U.K. cell production market, by technology 2014 - 2025 (USD Billion)
8.3.6.4 U.K. stem cell market, by type 2014 - 2025 (USD Billion)
8.4 Asia Pacific
8.4.1 Asia Pacific stem cell market, by product 2014 - 2025 (USD Billion)
8.4.1.1 Asia Pacific adult stem cell market, by product 2014 - 2025 (USD Billion)
8.4.2 Asia Pacific stem cell market, by application 2014 - 2025 (USD Billion)
8.4.2.1 Asia Pacific regenerative medicine market, by application 2014 - 2025 (USD Billion)
8.4.3 Asia Pacific stem cell market, by technology 2014 - 2025 (USD Billion)
8.4.3.1 Asia Pacific cell acquisition market, technology 2014 - 2025 (USD Billion)
8.4.3.2 Asia Pacific cell production market, by technology 2014 - 2025 (USD Billion)
8.4.4 Asia Pacific stem cell market, by type 2014 - 2025 (USD Billion)
8.4.5 Japan
8.4.5.1 Japan stem cell market, by product 2014 - 2025 (USD Billion)
8.4.5.1.1 Japan adult stem cell market, by product 2014 - 2025 (USD Billion)
8.4.5.2 Japan stem cell market, by application 2014 - 2025 (USD Billion)
8.4.5.2.1 Japan regenerative medicine market, by application 2014 - 2025 (USD Billion)
8.4.5.3 Japan stem cell market, by technology 2014 - 2025 (USD Billion)
8.4.5.3.1 Japan cell acquisition market, technology 2014 - 2025 (USD Billion)
8.4.5.3.2 Japan cell production market, by technology 2014 - 2025 (USD Billion)
8.4.5.4 Japan stem cell market, by type 2014 - 2025 (USD Billion)
8.4.6 China
8.4.6.1 China stem cell market, by product 2014 - 2025 (USD Billion)
8.4.6.1.1 China adult stem cell market, by product 2014 - 2025 (USD Billion)
8.4.6.2 China stem cell market, by application 2014 - 2025 (USD Billion)
8.4.6.2.1 China regenerative medicine market, by application 2014 - 2025 (USD Billion)
8.4.6.3 China stem cell market, by technology 2014 - 2025 (USD Billion)
8.4.6.3.1 China cell acquisition market, technology 2014 - 2025 (USD Billion)
8.4.6.3.2 China cell production market, by technology 2014 - 2025 (USD Billion)
8.4.6.4 China stem cell market, by type 2014 - 2025 (USD Billion)
8.5 Latin America
8.5.1 Latin America stem cell market, by product 2014 - 2025 (USD Billion)
8.5.1.1 Latin America adult stem cell market, by product 2014 - 2025 (USD Billion)
8.5.2 Latin America stem cell market, by application 2014 - 2025 (USD Billion)
8.5.2.1 Latin America regenerative medicine market, by application 2014 - 2025 (USD Billion)
8.5.3 Latin America stem cell market, by technology 2014 - 2025 (USD Billion)
8.5.3.1 Latin America cell acquisition market, technology 2014 - 2025 (USD Billion)
8.5.3.2 Latin America cell production market, by technology 2014 - 2025 (USD Billion)
8.5.4 Latin America stem cell market, by type 2014 - 2025 (USD Billion)
8.5.5 Brazil
8.5.5.1 Brazil stem cell market, by product 2014 - 2025 (USD Billion)
8.5.5.1.1 Brazil adult stem cell market, by product 2014 - 2025 (USD Billion)
8.5.5.2 Brazil stem cell market, by application 2014 - 2025 (USD Billion)
8.5.5.2.1 Brazil regenerative medicine market, by application 2014 - 2025 (USD Billion)
8.5.5.3 Brazil stem cell market, by technology 2014 - 2025 (USD Billion)
8.5.5.3.1 Brazil cell acquisition market, technology 2014 - 2025 (USD Billion)
8.5.5.3.2 Brazil cell production market, by technology 2014 - 2025 (USD Billion)
8.5.5.4 Brazil stem cell market, by type 2014 - 2025 (USD Billion)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa (MEA) stem cell market, by product 2014 - 2025 (USD Billion)
8.6.1.1 Middle East & Africa (MEA) adult stem cell market, by product 2014 - 2025 (USD Billion)
8.6.2 Middle East & Africa (MEA) stem cell market, by application 2014 - 2025 (USD Billion)
8.6.2.1 Middle East & Africa (MEA) regenerative medicine market, by application 2014 - 2025 (USD Billion)
8.6.3 Middle East & Africa (MEA) stem cell market, by technology 2014 - 2025 (USD Billion)
8.6.3.1 Middle East & Africa (MEA) cell acquisition market, technology 2014 - 2025 (USD Billion)
8.6.3.2 Middle East & Africa (MEA) cell production market, by technology 2014 - 2025 (USD Billion)
8.6.4 Middle East & Africa (MEA) stem cell market, by type 2014 - 2025 (USD Billion)
8.6.5 South Africa
8.6.5.1 South Africa stem cell market, by product 2014 - 2025 (USD Billion)
8.6.5.1.1 South Africa adult stem cell market, by product 2014 - 2025 (USD Billion)
8.6.5.2 South Africa stem cell market, by application 2014 - 2025 (USD Billion)
8.6.5.2.1 South Africa regenerative medicine market, by application 2014 - 2025 (USD Billion)
8.6.5.3 South Africa stem cell market, by technology 2014 - 2025 (USD Billion)
8.6.5.3.1 South Africa cell acquisition market, technology 2014 - 2025 (USD Billion)
8.6.5.3.2 South Africa cell production market, by technology 2014 - 2025 (USD Billion)
8.6.5.4 South Africa stem cell market, by type 2014 - 2025 (USD Billion)

Chapter 9 Competitive Profiles
9.1 Advanced Cell Technology Inc.
9.1.1 Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.2 STEMCELL Technologies Inc.
9.2.1 Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.3 BIOTIME, INC.
9.3.1 Company overview
9.3.2 Cell Cure Neurosciences LTD.
9.3.3 ESI BIO
9.3.4 Financial performance
9.3.5 Product benchmarking
9.3.6 Strategic initiatives
9.4 Cellular Engineering Technologies Inc.
9.4.1 Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.5 CellGenix GmbH
9.5.1 Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.6 PromoCell GmbH
9.6.1 Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.7 Lonza
9.7.1 Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.8 Kite Pharma
9.8.1 Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.9 Cellartis AB
9.9.1 Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.10 Angel Biotechnology
9.10.1 Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.11 BrainStorm Cell Therapeutics
9.11.1 Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.12 Celgene Corporation
9.12.1 Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.13 Osiris Therapeutics
9.13.1 Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.14 Genea BioCells
9.14.1 Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.15 Bioheart Inc.
9.15.1 Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.16 Waisman Biomanufacturing
9.16.1 Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.17 TiGenix
9.17.1 Company overview
9.17.2 Financial performance
9.17.3 Product benchmarking
9.17.4 Strategic initiatives
9.18 Caladrius
9.18.1 Company overview
9.18.2 Financial performance
9.18.3 Product benchmarking
9.18.4 Strategic initiatives
9.19 Gamida Cell.
9.19.1 Company overview
9.19.2 Financial performance
9.19.3 Product benchmarking
9.19.4 Strategic initiatives
9.20 pluristem
9.20.1 Company overview
9.20.2 Financial performance
9.20.3 Product benchmarking
9.20.4 Strategic initiatives
9.21 TiGenix
9.21.1 Company overview
9.21.2 Financial performance
9.21.3 Product benchmarking
9.21.4 Strategic initiatives

*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Advanced Cell Technology Inc.
  • STEMCELL Technologies Inc.
  • BIOTIME, INC.
  • Cellular Engineering Technologies Inc.
  • CellGenix GmbH
  • PromoCell GmbH
  • Lonza
  • Kite Pharma
  • Cellartis AB
  • Angel Biotechnology
  • BrainStorm Cell Therapeutics
  • Celgene Corporation
  • Osiris Therapeutics
  • Genea BioCells
  • Bioheart Inc.
  • Waisman Biomanufacturing
  • TiGenix
  • Caladrius
  • Gamida Cell.
  • pluristem
  • TiGenix
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4764577
Adroll
adroll